| Filed On | Filing |
|---|---|
| 29 Oct 2026 |
8-K: Results of Operations and Financial Condition
Sum of quarterly amounts may not equal year-to-date amounts due to rounding. |
| 13 Oct 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
____________________________________________________________________________ |
| 04 Aug 2026 |
8-K: Results of Operations and Financial Condition
Sum of quarterly amounts may not equal year-to-date amounts due to rounding. |
| 28 May 2026 |
8-K: Submission of Matters to a Vote of Security Holders
(a) The Annual Meeting of Shareholders of Merck & Co., Inc. (the “Company”) was held on May 26, 2026. |
| 22 May 2026 |
8-K: Other Events
Pursuant to the unanimous written consent and resolutions (collectively, the “Resolutions”) of the Board of Directors of Merck & Co., Inc. (the “Company”) (i) duly adopted and dated March 14, 2024 and (ii) adopted at a meeting duly calle... |
| 30 Apr 2026 |
8-K: Results of Operations and Financial Condition
Merck & Co., Inc., Rahway, N.J., USA Announces First-Quarter 2026 Financial Results; Highlights Significant Regulatory Approvals and Clinical Milestones |
| 03 Feb 2026 |
8-K: Results of Operations and Financial Condition
Sum of quarterly amounts may not equal year-to-date amounts due to rounding. |
| 04 Dec 2025 |
8-K: Other Events
Pursuant to the unanimous written consent and resolutions (collectively, the “Resolutions”) of the Board of Directors of Merck & Co., Inc. (the “Company”) (i) duly adopted and dated March 14, 2024 and (ii) adopted at a meeting duly calle... |
| 30 Oct 2025 |
8-K: Results of Operations and Financial Condition
Sum of quarterly amounts may not equal year-to-date amounts due to rounding. |
| 09 Sep 2025 |
8-K: Other Events
Pursuant to the unanimous written consent and resolutions (collectively, the “Resolutions”) of the Board of Directors of Merck & Co., Inc. (the “Company”) (i) duly adopted and dated March 14, 2024 and (ii) adopted at a meeting duly calle... |
| 29 Jul 2025 |
8-K: Results of Operations and Financial Condition; Costs Associated with Exit or Disposal Activities
Sum of quarterly amounts may not equal year-to-date amounts due to rounding. |
| 29 May 2025 |
8-K: Submission of Matters to a Vote of Security Holders
The Annual Meeting of Shareholders of Merck & Co., Inc. (the “Company”) was held on May 27, 2025. |
| 24 Apr 2025 |
8-K: Results of Operations and Financial Condition
Total Worldwide Sales Were $15.5 Billion, a Decrease of 2% From First Quarter 2024; Excluding the Impact of Foreign Exchange, Sales Grew 1% |
| 04 Feb 2025 |
8-K: Results of Operations and Financial Condition
Sum of quarterly amounts may not equal year-to-date amounts due to rounding. |
| 22 Nov 2024 |
8-K: Departure/Election of Directors or Officers; Compensation; Amendments to Articles/Bylaws; Change in Fiscal Year
SECTION 1. Annual Meeting. A meeting of the shareholders of Merck & Co., Inc. (hereinafter referred to as the “Company”) shall be held at such places as may from time to time be designated by the Board of Directors and stated in the noti... |
| 31 Oct 2024 |
8-K: Results of Operations and Financial Condition
Sum of quarterly amounts may not equal year-to-date amounts due to rounding. |
| 30 Jul 2024 |
8-K: Results of Operations and Financial Condition
Sum of quarterly amounts may not equal year-to-date amounts due to rounding. |
| 30 May 2024 |
8-K: Submission of Matters to a Vote of Security Holders; Other Events
Note: This reconciliation and tie shall not, for any purpose, be deemed to be a part of the Indenture. |
| 25 Apr 2024 |
8-K: Results of Operations and Financial Condition
Sales Reflect Continued Strong Growth in Oncology and Vaccines |
| 20 Feb 2024 |
8-K: Departure/Election of Directors or Officers; Compensation
(b) On February 15, 2024, Peter C. Wendell gave notice to Merck & Co., Inc. (the “Company”) of his intention to retire from the Board of Directors of the Company (the “Board”) as of the Company’s 2024 Annual Meeting of Shareholders on Ma... |
Loading...